SYNTHESIS OF TAXININE AND TAXOL
紫杉碱和紫杉醇的合成
基本信息
- 批准号:3181745
- 负责人:
- 金额:$ 8.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-05-01 至 1989-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The taxane diterpenes comprise a group of plant-derived natural products
possessing intriguing and important biological activity. In their
interaction with the cytoskeleta and constituent proteins, several of the
taxanes are unique among molecules acting on this cellular system and this
mode of action further manifests itself in significant anti-leukemic and
anti-tumor activity for several members of the group. In particular, taxol
is now undergoing clinical trial for possible use as a chemotherapeutic
agent against cancer. Low natural abundance of the taxanes, the desire to
identify sub-structural elements responsible for their biological activity,
the possibility that structurally modified taxanes might prove more
advantageous therapeutically, and the organic chemical interest in their
complex structures make these substances prime candidates for total
synthesis research.
The long range goal of the present research is to develop a general and
flexible synthesis of the taxanes thereby providing synthetic access to
natural substances of proven activity and to their structural analogues.
Specifically, the initial objective will be to construct taxinine, a taxane
possessing many structural features in common with the more complex and
biologically active members. This work will model, in part, the eventual
synthesis of taxol, representative of the most chemically and biologically
intriguing taxanes. Finally, the preparation of enantiomerically pure
taxanes, especially taxol, will be probed.
紫杉烷二萜包括一组植物衍生的天然产物
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES S SWINDELL其他文献
CHARLES S SWINDELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES S SWINDELL', 18)}}的其他基金
Angiocidin, a Novel Differentiation Agent for the Treatment of Leukemia
血管抑制素,一种治疗白血病的新型分化剂
- 批准号:
8521797 - 财政年份:2013
- 资助金额:
$ 8.21万 - 项目类别:
相似海外基金
MRI: Acquisition of an X-ray Diffractometer for Research and Training in Chemical Structure-Function Studies
MRI:购买 X 射线衍射仪用于化学结构-功能研究的研究和培训
- 批准号:
1726630 - 财政年份:2017
- 资助金额:
$ 8.21万 - 项目类别:
Standard Grant